Form 8-K Third Harmonic Bio, Inc. For: Feb 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Raymond James Downgrades Third Harmonic Bio (THRD) to Market Perform
February 11, 2025 10:58 AM ESTRaymond James analyst Laura Prendergast downgraded Third Harmonic Bio (NASDAQ: THRD) from Outperform to Market Perform.
The analyst comments "Third Harmonic Bio (THRD) presented Phase 1 healthy volunteer data for THB335 (slides). Although data supports advancement to Phase 2, it does not support a best in class profile as robust tryptase reduction is associated with hematological AEs (hemoglobin decrease). This toxicity will likely limit THB335 to doses that... More
